As previously mentioned, SMYD3 has been found highly overexpressed in several types of cancers [1], with a preponderance of GI malignancies, in which SMYD3 overexpression correlates with poor prognosis and promotes cancer growth, migration and invasion. The gene discussed is SMYD3; the disease is cancer.